GSK Canada
Member Profile
GSK is a fully focused biopharma company with a new purpose: to unite science, technology and talent to get ahead of disease together.
We aim to impact the health of 2.5 billion people over the next 10 years. Our bold ambitions for patients are reflected in new commitments to growth and step-change in performance. GSK will be a company where outstanding people can thrive.
Sector
Global Pharmaceutical Corporations, Therapeutics
Global Pharmaceutical Corporations, Therapeutics
Area of Expertise
- Bioinformatics
- Bioprocessing
- Bioproducts
- Cardiovascular Disease
- Disease Prevention
- Distributor
- Drug Delivery
- Drug Discovery
- Infectious Diseases
- Manufacturer
- Oncology
- Product Development
- Therapeutics
- Vaccines
- Wellness solutions
- Women’s Health
Investment Stage
Public Company
Public Company
Stock Ticker GSK - LON
Member Profile
Global Pharmaceutical Corporations, Therapeutics
GSK Canada
Gold Sponsor
- Website ca.gsk.com/en-ca/
- Phone +1 (905) 819 3000
- Address
100 Milverton Drive, Suite 800
Mississauga, ON
L5R 4H1 - Leadership Contact
Sridhar Venkatesh, President & General Manager
February 26, 2025
GSK’s Nucala (mepolizumab) Accepted for Review by Health Canada for the Treatment of COPD
February 25, 2025
National Survey Reveals Low Understanding of Shingles Risk Factors and Lack of Concern Among Those at Increased Risk
February 13, 2025
Canada’s Drug Agency Recommends OJJAARA for Public Reimbursement
No current content.